학술논문
330 (PB110) - Evaluation of membrane type 1 metalloproteinase (MT1-MMP/MMP14) expression as a prognostic biomarker in patients with solid tumours screened for a Phase I/II trial
Document Type
Abstract
Author
Source
In European Journal of Cancer October 2022 174 Supplement 1:S117-S118
Subject
Language
ISSN
0959-8049